search
Back to results

RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT) (ORBIT)

Primary Purpose

Bipolar Disorder, Currently in Remission

Status
Completed
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Mindfulness for Bipolar
Psychoeducation for Bipolar
Sponsored by
Swinburne University of Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Bipolar Disorder, Currently in Remission focused on measuring stage, online, self-help, coaching support, quality of life, mindfulness, psychoeducation, persuasive systems design, psychosocial

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

To ensure ready translation, minimally restrictive inclusion and exclusion criteria will be set.

Inclusion Criteria:

  • diagnosis of BD from a mental health professional
  • diagnosis of BD (BD I, BD II or Other Specified Bipolar and Related Disorder) confirmed by semi-structured interview using DSM-5 (Diagnostic and statistical manual of mental disorders-5) criteria, excluding criteria that mania/hypomania require abnormalities of activity/energy.
  • must have experienced 10 or more episodes of mania, hypomania or depression
  • must be under the care of and able to provide phone/mail contact details for a nominated medical practitioner
  • must have local access to emergency services
  • must have sufficient understanding of written and spoken English
  • must have ready daily access to the internet and adequate internet literacy
  • aged between 18 - 65 years

Exclusion criteria:

  • currently experiencing an episode of depression or hypo/mania
  • currently psychotic or actively suicidal

Sites / Locations

  • Swinburne University of Technology

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Mindfulness for Bipolar

Psychoeducation for Bipolar

Arm Description

Introduction to, and training in the skills of mindfulness, self-compassion, and values-oriented action, and how these can be applied to managing symptoms of bipolar disorder.

Information about bipolar disorder and the patient's role in managing the condition, including identifying triggers, and responding to early warning signs of episodes, and developing a healthy lifestyle

Outcomes

Primary Outcome Measures

Change in Brief QoL.BD
Self-report measure to assess quality of life.

Secondary Outcome Measures

Change in Montgomery-Asberg Depression Scale (MADRS)
A clinician-rated scale to assess depression symptoms.
Change in Young Mania Rating Scale (YMRS)
A clinician-rated scale to assess manic symptoms.
Change in Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR)
A self-report measure of depression.
Change in Depression Anxiety Stress Scale (DASS-21, Anxiety and Stress Scales only)
A self-report measure of anxiety and stress symptoms.
Change in Functional Assessment Staging Test (FAST)
A clinician-rated scale to assess functioning across 6 different domains.
Change in Pittsburgh Sleep Quality Index (PSQI)
A self-report measure of sleep quality.
Change in Sleep, Circadian Rhythms and Mood questionnaire (SCRAM)
A self-report measure to assess overlap between sleep, circadian rhythms and mood.
Occurrence of intervention-related relapse
Using the Time to Intervention for Mood Episode (TIME) and a modified version of the MINI International Neuropsychiatric Interview (MINI) to determine treatment-related relapse events.

Full Information

First Posted
June 21, 2017
Last Updated
November 29, 2020
Sponsor
Swinburne University of Technology
Collaborators
University of British Columbia, National Health and Medical Research Council, Australia, University of California, Berkeley, Lancaster University, Deakin University, Australian National University
search

1. Study Identification

Unique Protocol Identification Number
NCT03197974
Brief Title
RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT)
Acronym
ORBIT
Official Title
Web-based Intervention With Email Support to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT): Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
September 14, 2017 (Actual)
Primary Completion Date
May 29, 2019 (Actual)
Study Completion Date
May 29, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Swinburne University of Technology
Collaborators
University of British Columbia, National Health and Medical Research Council, Australia, University of California, Berkeley, Lancaster University, Deakin University, Australian National University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to improve outcomes in people with bipolar disorder (BD) by comparing two new online interventions specifically designed to improve quality of life amongst people who have had multiple (10 or more) episodes of BD.
Detailed Description
People who have had significant experience with bipolar disorder (defined here as 10 or more episodes) may not benefit from existing psychosocial interventions targeting symptoms and relapse, and may be better served by interventions targeting quality of life (QoL). Our international team of researchers, clinicians and consumers has developed two different online interventions, both of which there is reason to believe will be useful. Both interventions are brief, with 4 weeks of new online content released weekly, plus one additional week of application. This 5-week 'active phase' is supported by email contact with a personal online coach. The remainder of the 6 months of participant involvement in the trial includes continued access to the website (without coaching support) and follow-up assessments. Both arms are equivalent in using cutting-edge internet technologies and design features to help people engage with the therapeutic content and generalise it into their real lives. The websites have been developed following best-practice principles of persuasive system design, and rely heavily on consumer videos, social engagement through discussion boards, personalised feedback, and intuitive content structure to maximise engagement. Australia's NHMRC has funded a 4-year project (2016-2019) to develop and compare the effectiveness of the two websites in terms of a range of outcomes, primarily QoL. The randomized controlled trial (RCT) will definitively assess the QoL benefits of two websites for late stage Bipolar Disorder. The RCT has been designed to optimise various aims: minimise risk of bias to support definitive scientific findings (internal validity), support ready dissemination should outcomes be positive (external validity, end-user involvement), and to optimally manage the risks inherent in the population being studied. We expect to find definitive evidence of the comparative QoL benefits of the two interventions, and insights about secondary outcomes including self-rated state anxiety, self-rated depression, and clinician-rated depression. A number of clinical and functional secondary outcomes will also be explored, as will hypothesised mediators and baseline moderators of QoL outcomes. Economic analysis based on cost-consequence analysis, and a range of process evaluations will also be conducted. A total of 300 participants will be block randomised to provide power to identify a small-moderate treatment effect on QoL. Participants will be blinded as to the experimental intervention. The study uses a single-site (internet-based) design, with advertising occurring primarily online, but also through traditional methods via clinical networks of the researchers in Australia, United Kingdom (UK), Canada and the US. Major assessment time points are baseline, post-treatment (primary endpoint), 3 months post-baseline and 6 months post-baseline. Participants will be remunerated for assessments, which include both online questionnaires and a (blinded) semi-structured clinical interview by phone. A multi-layered risk-management approach has been developed based on our experience with online interventions for bipolar disorder and psychosis. First and foremost, we explain to participants that their participation does not replace usual care, and no emergency assistance is available through the website (a link to the international site unsuicide is provided). This devolving of responsibility to the participant is reinforced by the inclusion criterion of being under the care of a medical practitioner and having access to local emergency services. Second, both intervention sites contain general information about the potential risks (e.g., generating distress) of the interventions, as well as specific alerts to the potential challenges of particular exercises. Third, a comprehensive 'red flag decision tree' has been developed to guide the team's response to any risk issues arising (see Table 2). Finally, any adverse events arising will be reviewed weekly in the trial executive committee.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Disorder, Currently in Remission
Keywords
stage, online, self-help, coaching support, quality of life, mindfulness, psychoeducation, persuasive systems design, psychosocial

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
It is a prospective, parallel group, rater-blind, superiority RCT with a 1:1 allocation ratio comparing two websites designed to improve QoL in late stage bipolar disorder. Follow-up time points are immediate post-treatment (primary outcome timepoint), 3-month and 6-month follow-ups. To minimise the risk of bias, we are not publicising which arm is expected to be superior in terms of the primary outcome. Note that we expect that both arms will lead to QoL benefits, and the statistical analysis plan is agnostic about the superiority of the experimental intervention over active control on a number of secondary outcome variables. In both arms, usual management will continue throughout, with medication and psychosocial intervention changes monitored at follow-up interviews. The study setting is online, and participation in both arms will be through a secure server at Swinburne University's National eTherapy Centre (NetC).
Masking
ParticipantOutcomes Assessor
Masking Description
Outcomes Assessors will be blinded as to treatment allocation. To maintain blinding, the Assessor will not be involved in intervention delivery and participants will be instructed not to discuss treatment with their interviewer. When an interview leads to unblinding, the assessor will be replaced. Participants will be blinded as to the primary hypothesis of which website will have superior benefits for QoL, but will of course be aware of the intervention they receive.
Allocation
Randomized
Enrollment
302 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Mindfulness for Bipolar
Arm Type
Other
Arm Description
Introduction to, and training in the skills of mindfulness, self-compassion, and values-oriented action, and how these can be applied to managing symptoms of bipolar disorder.
Arm Title
Psychoeducation for Bipolar
Arm Type
Other
Arm Description
Information about bipolar disorder and the patient's role in managing the condition, including identifying triggers, and responding to early warning signs of episodes, and developing a healthy lifestyle
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness for Bipolar
Intervention Description
Brief online self-management program with email coaching support
Intervention Type
Behavioral
Intervention Name(s)
Psychoeducation for Bipolar
Intervention Description
Brief online self-management program with email coaching support
Primary Outcome Measure Information:
Title
Change in Brief QoL.BD
Description
Self-report measure to assess quality of life.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Secondary Outcome Measure Information:
Title
Change in Montgomery-Asberg Depression Scale (MADRS)
Description
A clinician-rated scale to assess depression symptoms.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Young Mania Rating Scale (YMRS)
Description
A clinician-rated scale to assess manic symptoms.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR)
Description
A self-report measure of depression.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Depression Anxiety Stress Scale (DASS-21, Anxiety and Stress Scales only)
Description
A self-report measure of anxiety and stress symptoms.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Functional Assessment Staging Test (FAST)
Description
A clinician-rated scale to assess functioning across 6 different domains.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Pittsburgh Sleep Quality Index (PSQI)
Description
A self-report measure of sleep quality.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Sleep, Circadian Rhythms and Mood questionnaire (SCRAM)
Description
A self-report measure to assess overlap between sleep, circadian rhythms and mood.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Occurrence of intervention-related relapse
Description
Using the Time to Intervention for Mood Episode (TIME) and a modified version of the MINI International Neuropsychiatric Interview (MINI) to determine treatment-related relapse events.
Time Frame
Immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Other Pre-specified Outcome Measures:
Title
Change in Resource Use Questionnaire
Description
A self-report measure of health service use.
Time Frame
Baseline, 3 and 6 months.
Title
Change in Assessment of Quality of Life 8dimension (AQol8d)
Description
A self-report measure of quality of life.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Five Facet Mindfulness Questionnaire (FMQ)
Description
A self-report measure of mindfulness.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Self-Compassion Scale (SCS)
Description
A self-report measure of self-compassion.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Difficulties in Emotion Regulation Scale-16 Item (DERS-16)
Description
A self-report measure to assess multiple aspects of emotion dysregulation.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Ruminative Responses Scale (section of the Response Styles Questionnaire)
Description
A self-report measure of tendency to ruminate.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Responses to Positive Affect scale (RPA)
Description
A self-report measure to assess rumination and dampening.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Non-attachment to Ego Scale
Description
A self-report measure to assess non-attachment to self.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in Depressive Experience Questionnaire Self-Criticism Six-Item Scale (DEQ-SC6)
Description
A self-report measure to assess self-criticism.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in the Short revised almost perfect scale (SAPS)
Description
A self-report measure to assess perfectionism.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.
Title
Change in adherence to medication.
Description
Self-reported adherence to medication.
Time Frame
Baseline, immediately post-intervention (post the 5 week active phase), 3 and 6 months.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
To ensure ready translation, minimally restrictive inclusion and exclusion criteria will be set. Inclusion Criteria: diagnosis of BD from a mental health professional diagnosis of BD (BD I, BD II or Other Specified Bipolar and Related Disorder) confirmed by semi-structured interview using DSM-5 (Diagnostic and statistical manual of mental disorders-5) criteria, excluding criteria that mania/hypomania require abnormalities of activity/energy. must have experienced 10 or more episodes of mania, hypomania or depression must be under the care of and able to provide phone/mail contact details for a nominated medical practitioner must have local access to emergency services must have sufficient understanding of written and spoken English must have ready daily access to the internet and adequate internet literacy aged between 18 - 65 years Exclusion criteria: currently experiencing an episode of depression or hypo/mania currently psychotic or actively suicidal
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Greg Murray
Organizational Affiliation
Swinburne University of Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Swinburne University of Technology
City
Hawthorn
State/Province
Victoria
ZIP/Postal Code
3122
Country
Australia

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
30001704
Citation
Fletcher K, Foley F, Thomas N, Michalak E, Berk L, Berk M, Bowe S, Cotton S, Engel L, Johnson SL, Jones S, Kyrios M, Lapsley S, Mihalopoulos C, Perich T, Murray G. Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol. BMC Psychiatry. 2018 Jul 13;18(1):221. doi: 10.1186/s12888-018-1805-9.
Results Reference
derived

Learn more about this trial

RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolar Disorder (ORBIT)

We'll reach out to this number within 24 hrs